# IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
Canonical URL: https://biopharmsignal.com/news/IRMD/iradimed-corporation-to-present-at-the-goldman-sachs-47th-annual-global-healthca-01c6b756
Ticker: IRMD
Company: iRadimed
Source: iRadimed
Published: 2026-05-20 12:30 EST
## Summary

IRADIMED CORPORATION (NASDAQ: IRMD), a leader in developing innovative MRI-compatible medical devices,...

## Article Body
IRADIMED CORPORATION (NASDAQ: IRMD), a leader in developing innovative MRI-compatible medical devices, today announced that Roger Susi, President and Chief Executive Officer, and Jack Glenn, Chief Financial Officer, will attend the Goldman Sachs 47th Annual Global Healthcare Conference, to be held June 8–10, 2026, at the Loews Miami Beach Hotel, Miami Beach, Florida.

Investors interested in meeting with Iradimed management during the conference may contact their Goldman Sachs representative to schedule a one-on-one meeting.

About IRADIMED CORPORATION

IRADIMED CORPORATION is a leader in developing innovative Magnetic Resonance Imaging ("MRI") compatible medical devices. We design, manufacture, market, and distribute MRI-compatible medical devices, accessories, disposables, and related services. We are the only known provider of a non-magnetic intravenous ("IV") infusion pump system specifically designed to be safe for use during MRI procedures. Our patented MRidium® MRI-compatible IV infusion pump systems and our 3880 MRI-compatible patient vital signs monitoring system are designed to enable accurate, safe, and dependable care before, during, and after MRI procedures. For more information, please visit www.iradimed.com .

For more information, please visit www.iradimed.com .

Media Contact: Jack Glenn Chief Financial Officer Iradimed Corporation (407) 677-8022 InvestorRelations@iradimed.com
## Recent Company News
- 2026-07-24 20:15 EST — [IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026](https://biopharmsignal.com/news/IRMD/iradimed-corporation-to-hold-second-quarter-2026-financial-results-conference-ca-de1ca3b1) — Source: iRadimed
- 2026-05-20 12:30 EST — [IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference](https://biopharmsignal.com/news/IRMD/iradimed-corporation-to-present-at-the-goldman-sachs-47th-annual-global-healthca-01c6b756) — Source: iRadimed
- 2026-05-01 12:30 EST — [IRADIMED CORPORATION Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/IRMD/iradimed-corporation-reports-first-quarter-2026-financial-results-2aefa164) — Source: iRadimed
- 2026-04-27 12:30 EST — [IRADIMED CORPORATION to Hold First Quarter 2026 Financial Results Conference Call on May 1, 2026](https://biopharmsignal.com/news/IRMD/iradimed-corporation-to-hold-first-quarter-2026-financial-results-conference-cal-0f6dd0ae) — Source: iRadimed
- 2026-04-10 19:14 EST — [IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference](https://biopharmsignal.com/news/IRMD/iradimed-corporation-to-participate-at-the-25th-annual-needham-virtual-healthcar-a4af6e99) — Source: iRadimed
## Related News
- 2026-07-28 20:15 EST — BDX — [BD Board Declares Dividend](https://biopharmsignal.com/news/BDX/bd-board-declares-dividend-ea66eb4a)
- 2026-07-28 13:00 EST — ENLV — [Enlivex Announces $400,000,000 Private Placement](https://biopharmsignal.com/news/ENLV/enlivex-announces-400-000-000-private-placement-20e71a7a)
- 2026-07-28 12:30 EST — XRAY — [Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship](https://biopharmsignal.com/news/XRAY/dentsply-sirona-advances-commercial-growth-strategy-in-canada-through-expanded-m-e2440bb2)
- 2026-07-28 12:30 EST — RLMD — [Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer](https://biopharmsignal.com/news/RLMD/relmada-therapeutics-appoints-uro-oncology-leader-bipin-dalmia-as-chief-business-5c4d7b11)
- 2026-07-28 12:05 EST — RIGL — [Rigel Announces Conference Call and Webcast to Report Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/RIGL/rigel-announces-conference-call-and-webcast-to-report-second-quarter-2026-financ-5b987d7a)